Jian-feng Li

State Key Laboratory Of Medical Genomics
Shanghai, 200025, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Molecular insight into the interplay among heterogeneous plasmacytes and microenvironment cells and their clinical relevance in myeloma.

Molecular insight into the interplay among heterogeneous plasmacytes and microenvironment cells and their clinical relevance in myeloma.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: May 19, 2026

HSCs/MPPs as cells of origin with altered differentiation hierarchy impairing immunomicroenvironment in PML::RARA and CBFα/β fusion AML.

HSCs/MPPs as cells of origin with altered differentiation hierarchy impairing immunomicroenvironment in PML::RARA and CBFα/β fusion AML.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: February 06, 2026

Differences in response to immunotherapy drugs including blinatumomab and inotuzumab ozogamicin in B-ALL patients.

Differences in response to immunotherapy drugs including blinatumomab and inotuzumab ozogamicin in B-ALL patients.

Journal: International journal of hematology

Published: December 23, 2024

Proteomic subtypes enrich current acute myeloid leukemia nomenclature and reflect intrinsic pathogenesis alongside aging.

Proteomic subtypes enrich current acute myeloid leukemia nomenclature and reflect intrinsic pathogenesis alongside aging.

Journal: Blood

Published: November 15, 2024

Indoleamine 2,3-dioxygenase 1 alters the proportions of B cell subpopulations in the microenvironment of acute myeloid leukemia.

Indoleamine 2,3-dioxygenase 1 alters the proportions of B cell subpopulations in the microenvironment of acute myeloid leukemia.

Journal: Molecular biomedicine

Published: July 29, 2024

Aging and comprehensive molecular profiling in acute myeloid leukemia.

Aging and comprehensive molecular profiling in acute myeloid leukemia.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: February 29, 2024

Molecular heterogeneity of BCL2/MYC double expressor lymphoma underlies sensitivity to histone deacetylase inhibitor.

Molecular heterogeneity of BCL2/MYC double expressor lymphoma underlies sensitivity to histone deacetylase inhibitor.

Journal: Clinical and translational medicine

Published: February 26, 2024

The impact of age and number of mutations on the size of clonal hematopoiesis.

The impact of age and number of mutations on the size of clonal hematopoiesis.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: February 15, 2024

Genetic subtype-guided immunochemotherapy in diffuse large B cell lymphoma: The randomized GUIDANCE-01 trial.

Genetic subtype-guided immunochemotherapy in diffuse large B cell lymphoma: The randomized GUIDANCE-01 trial.

Journal: Cancer cell

Published: February 28, 2023

Transcriptome-based molecular subtypes and differentiation hierarchies improve the classification framework of acute myeloid leukemia.

Transcriptome-based molecular subtypes and differentiation hierarchies improve the classification framework of acute myeloid leukemia.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: November 28, 2022

Transcriptome-wide subtyping of pediatric and adult T cell acute lymphoblastic leukemia in an international study of 707 cases.

Transcriptome-wide subtyping of pediatric and adult T cell acute lymphoblastic leukemia in an international study of 707 cases.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: April 06, 2022

Ibrutinib, rituximab, and lenalidomide in unfit or frail patients aged 75 years or older with de novo diffuse large B-cell lymphoma: a phase 2, single-arm study.

Ibrutinib, rituximab, and lenalidomide in unfit or frail patients aged 75 years or older with de novo diffuse large B-cell lymphoma: a phase 2, single-arm study.

Journal: The lancet. Healthy longevity

Published: January 17, 2022

Showing 1-12 of 16

Last Updated: 09/26/2026